Oculis Holding AG (OCS) Operating Leases (2021 - 2026)
Oculis Holding AG (OCS) posted quarterly Operating Leases of $2.3 million for Q1 2026, up 163.25% year-over-year from $888688.2 in Q1 2025, and up 3.25% quarter-over-quarter from $2.3 million in Q4 2025.
Oculis Holding AG (OCS) Operating Leases (2021 - 2026) Analysis & Trends
Oculis Holding AG's Operating Leases history runs 6 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Operating Leases rose 163.25% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 163.25% YoY), while the FY2025 annual figure was $2.2 million, up 122.15% from the prior year.
- Operating Leases for Q1 2026 stood at $2.3 million, up from $2.3 million in the prior quarter.
- The five-year high for Operating Leases was $2.6 million in Q3 2025, with the low at $470875.4 in Q1 2024.
- The 5-year median for Operating Leases is $888688.2 (2025), against an average of $1.2 million.
- The sharpest annual moves came in 2025 and 2026: Operating Leases declined 22.21% in 2025, then soared 163.25% in 2026.
- Oculis Holding AG's Operating Leases stood at $657067.9 in 2022, then grew by 3.8% to $682049.5 in 2023, then jumped by 44.77% to $987416.4 in 2024, then jumped by 129.47% to $2.3 million in 2025, then gained by 3.25% to $2.3 million in 2026.
- Business Quant data shows OCS's Operating Leases at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 869,680.96 |
| Mar 31, 2025 | 888,688.18 |
| Dec 31, 2024 | 987,416.40 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 470,875.43 |
| Dec 31, 2023 | 682,049.46 |
| Sep 30, 2023 | 571,737.04 |
| Jun 30, 2023 | 599,462.62 |
| Dec 31, 2022 | 657,067.87 |
| Dec 31, 2021 | 625,757.71 |